PuSH - Publikationsserver des Helmholtz Zentrums München

Oertel, W.H. ; Müller, H.H.* ; Unger, M.M.* ; Schade-Brittinger, C.* ; Balthasar, K.* ; Articus, K.* ; Brinkman, M.* ; Venuto, C.S.* ; Tracik, F.* ; Eberling, J.* ; Eggert, K.M.* ; Kamp, C.* ; Kieburtz, K.* ; Boyd, J.T.*

Transdermal nicotine treatment and progression of early Parkinson's disease.

NEJM Evid. 2:EVIDoa2200311 (2023)
DOI PMC
Nicotine Treatment and Parkinson's DiseaseIn this randomized, controlled trial, patients with Parkinson's disease not on dopaminergic therapy were randomly assigned to receive transdermal nicotine or placebo. After 1 year, there was no difference in the change in Total Unified Parkinson's Disease Rating Scale score between groups.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
ISSN (print) / ISBN 2766-5526
e-ISSN 2766-5526
Zeitschrift NEJM Evidence
Quellenangaben Band: 2, Heft: 9, Seiten: , Artikelnummer: EVIDoa2200311 Supplement: ,
Verlag NEJM Group
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Neurogenomics (ING)